Novartis fined $422.5M in marketing, kickback case

By KATHY MATHESON 2010-09-30T22:14:41Z PHILADELPHIA (AP) -- Novartis Pharmaceuticals Corp. will pay $422.5 million in penalties for marketing an epilepsy medicine for unapproved uses and for paying kickbacks to doctors to prescribe it and five other drugs, federal officials announced Thursday....

Read the whole article on AP Health

More from AP Health